Innovative implantable bio-artificial pancreas for the treatment of diabetes patients No More Frequent Glucose Monitoring & Insulin Injections Beta-O2  is Proposing a Life-Changing Benefit to Diabetes Patients  
 
 

About Us

Investors

Vitalife Life Sciences Fund

Vitalife Life Sciences Fund was established by a team of medical and financial investment experts who saw the profitable global trends in the life sciences field and who could appreciate the revolutionary nature of medical innovations of numerous early stage start-ups. Vitalife works together with its portfolio companies as a team to build successful life science companies and in parallel to earn the best return for its investors. Vitalife is represented globally through its sponsors and strategic investors. Vitalife Life Sciences Fund investors include fund sponsor Discount Capital Markets & Investments, SCP Private Equity Partners, L.P., Boston Scientific Corp and HarbourVest.
www.vitalifevc.com

Pitango Venture Capital

Pitango Venture Capital is one of Israel’s leading venture capital firms. Now in its thirteenth year, Pitango has helped cultivate more than 100 companies in seed, early and expansion stage in a diversified range of technology sectors. Pitango manages funds in excess of $1 billion in committed capital from well-established international investors from the firm’s offices in Israel and the Silicon Valley. Pitango, through its team of investment professionals, has earned a solid reputation for nurturing innovation and working hand-in-hand with entrepreneurs in building sustainable and successful businesses.
www.pitango.com

Saints Capital

Saints' investing activities focus on special situations and particularly on direct secondary investing. We acquire illiquid investments in private companies from investors or founders looking to monetize these investments or eliminate the requirement for further investment or management. Saints has developed particular expertise in the rapid evaluation and structuring of complex secondary market transactions. Saints is currently investing out of Saints Capital VI, LP, a blind pool fund. Hence, we have the capability to evaluate investment opportunities ranging in size from less than $5 million to upwards of $200 million. Saints will take over the ongoing management of the investments internally or in conjunction with members of the existing general partner or management team.
www.saintsvc.com

The Heznek Fund

The Heznek Fund, the seed fund of the Israeli Ministry of Trade & Industry, is intended to provide incentives for investing in seed-stage companies. Heznek is a conduit for joint government and external investors’ investment in start-ups. Investors receive preferred shares and an option to acquire the state’s stake in the companies at any time in the first five years from the date of the investment.
www.tamas.gov.il/NR/exeres/7F83758F-3C0E-42A6-80CA-63A4616E8097.htm
 
© Beta-O2 - Implantable bio-artificial pancreas for the treatment of diabetes     Back to Top  |  Legal Notice